All Avastin articles
-
Business
Novartis accused of ‘derailing’ trials for cheap eye disease drug
BMJ says pharma giant is trying to block access to a drug that would save the NHS millions
-
Business
Review says cheaper drug is safe for eye disease
Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar
-
Business
Drug companies rapped for anticompetitive behaviour
Italian authorities demand €1.2 billion in damages from Roche, Novartis and Pfizer